Skip to search formSkip to main contentSkip to account menu

erythrogenic toxin

Known as: streptococcal erythrogenic toxin, streptococcal pyrogenic exotoxin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
We examined T‐cell receptor (TCR) usage, cytokine production and antibody responses to superantigens in patients with Kawasaki… 
Highly Cited
1999
Highly Cited
1999
Although bacterial superantigens have been well characterized as potent stimulators of T cells, their role in natural killer (NK… 
Highly Cited
1996
Highly Cited
1996
Infections with Streptococcus pyogenes (group A streptococcus) can result in the recently described streptococcal toxic shock… 
Highly Cited
1994
Highly Cited
1994
The influence of pooled human IgG preparations for intravenous use (IVIg) on cytokine production induced by streptococcal… 
Highly Cited
1993
Highly Cited
1993
Intravenous injection of toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus, can reactivate arthritis in a… 
Highly Cited
1990
Highly Cited
1990
We investigated the mechanisms of murine T cell activation by streptococcal pyrogenic exotoxin type A (SPE A), focusing on the… 
Highly Cited
1978
Highly Cited
1978
Streptococcal pyrogenic exotoxin type B purified from culture filtrates of either the NY-5 or T-19 strain of group A… 
Highly Cited
1978
Highly Cited
1978
Group A streptococcal pyrogenic exotoxin type C (SPE C) was shown to produce fever by crossing the blood-brain barrier. The toxin… 
Highly Cited
1977
Highly Cited
1977
Group A streptococcal pyrogenic exotoxin (SPE) type C was partially purified by differential solubility in ethanol and acetate… 
Highly Cited
1968
Highly Cited
1968
In rabbits, purified streptococcal pyrogenic exotoxin, at 0.002 of the ld50 dose, suppressed the antibody response to injected…